31 reports

  • RNA Aptamer
  • 6.3 RNA-BASED APTAMERS
  • RNA
  • Aptamer Sciences Inc.
  • Base Pair Biotechnologies, Inc.
  • SomaLogic, Inc.
  • Vivonics, Inc.
  • LOW REPRESENTATION OF MIRNA AMONG RNA SPECIES
  • THREE: MIRNA PROFILING AND FUNCTIONAL ANALYSIS TECHNOLOGIES 73
  • RNA
  • Illumina, Inc.
  • Mirna Therapeutics, Inc.
  • QIAGEN N.V.
  • Sigma-Aldrich

Indicated by CTC cfDNA-RNA 2015 participants Table ##. ##.

  • Genomics
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • RNA
  • HTG MOLECULAR DIAGNOSTICS
  • SELECTED MOLECULAR HISTOLOGY INNOVATIONS, 2015

THE SIMPLIFIED QNPA PROTOCOL REQUIRES NO RNA EXTRACTION, NO RNA AMPLIFICATION, AND NO RNA LABELING, REMOVING THE MANIPULATIONS THAT INTRODUCE VARIABILITY IN OTHER TECHNOLOGIES.

  • RNA
  • United States
  • NanoString Technologies, Inc.
  • QIAGEN N.V.
  • Roche Group
  • 2.2.3 RNA
  • 2.3.4 CIRCULATING RNA IN PREGNANCY
  • RNA
  • Ariosa Diagnostics, Inc.
  • Illumina, Inc.
  • Natera, Inc.
  • Sequenom, Inc.
  • 2.2.3 RNA
  • 2.2.2 CIRCULATING EXTRACELLULAR DNA
  • RNA
  • Affymetrix, Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Roche Group
  • Company Overview
  • QIAGEN ACQUIRES EXIQON FOR UP TO USD102.4 MILLION

Exiqon offers services such as RNA isolation services, microRNA PCR service, sequencing, xploreRNA, microRNA ISH services and custom pharma service.

  • microRNA
  • Pharmaceutical
  • RNA
  • Denmark
  • Exiqon A/S
  • EOSCAPE-HCV RNA - PRODUCT DESCRIPTION
  • EOSCAPE-HCV RNA - PRODUCT STATUS
  • Hepatitis
  • RNA
  • United States
  • Company
  • GlobalData's company
  • BIOSEARCH TECHNOLOGIES EXTENDS LICENSING AGREEMENT WITH UNIVERSITY OF MEDICINE AND DENTISTRY...
  • BIOSEARCH TECHNOLOGIES ACQUIRES MAJORITY STAKE IN LIGHTSPEED GENOMICS
  • Genomics
  • RNA
  • United States
  • M&A
  • Biosearch Technologies, Inc.
  • ESYSTEM - QUALITATIVE HCV RNA ASSAY - PRODUCT DESCRIPTION
  • ESYSTEM - QUALITATIVE HCV RNA ASSAY - PRODUCT STATUS
  • Clinical Trial
  • Hepatitis
  • Molecular Diagnostic
  • RNA
  • GlobalData's company
  • BIOSEARCH TECHNOLOGIES EXTENDS LICENSING AGREEMENT WITH UNIVERSITY OF MEDICINE AND DENTISTRY...
  • DEAL SUB TYPE
  • Pharmaceutical
  • RNA
  • United States
  • M&A
  • GlobalData's company
  • FEB 11, 2016: QIAGEN LAUNCHES TARGETED RNA PANELS FOR NEXT-GENERATION SEQUENCING
  • FEB 11, 2016: QIAGEN LAUNCHES TARGETED RNA PANELS FOR NEXT-GENERATION SEQUENCING
  • RNA
  • United States
  • Company Financials
  • Demand
  • QIAGEN N.V.
  • BIOSEARCH TECHNOLOGIES EXTENDS LICENSING AGREEMENT WITH UNIVERSITY OF MEDICINE AND DENTISTRY...
  • WAFERGEN BIOSYSTEMS ENTERS INTO LICENSING AGREEMENT WITH RUTGERS UNIVERSITY FOR RNA...
  • Pharmaceutical
  • RNA
  • United States
  • Deals & Alliance
  • GlobalData's company
  • JUN 15, 2017: PROQR R&D DAY HIGHLIGHTS PROGRESS ON PIPELINE AND INTRODUCES AXIOMER, A NOVEL...
  • AUG 17, 2016: PROQR ANNOUNCES RESULTS FOR THE SECOND QUARTER OF 2016
  • Genomics
  • RNA
  • United States
  • Company
  • ProQR Therapeutics N.V.
  • SMALL MOLECULE TO TARGET RNA FOR MYOTONIC DYSTROPHY - DRUG PROFILE
  • SMALL MOLECULES TO TARGET RNA FOR MYOTONIC DYSTROPHY - DRUG PROFILE
  • Pharmaceutical
  • RNA
  • United States
  • World
  • Product Initiative
  • Indication
  • NANOSTRING TECHNOLOGIES INC COMPANY SNAPSHOT
  • Breast Cancer
  • Gene Expression
  • RNA
  • United States
  • NanoString Technologies, Inc.
  • PIPELINE BY RIGONTEC GMBH, H1 2017
  • (SB-9200 + HBV NUCLEOSIDE/TIDES) - DRUG PROFILE

Efficacy in liver was evaluated by changes in levels of viral DNA, RNA, and antigens.

  • Hepatitis
  • RNA
  • World
  • Product Initiative
  • Rigontec GmbH
  • Application
  • Indication
  • Genomics
  • Pathology
  • RNA
  • United States
  • GlobalData's company
  • Indication
  • Application
  • Diagnostics
  • Prostate Cancer
  • RNA
  • United States
  • Exosome Diagnostics, Inc.
  • FTD HEPATITIS E RNA ASSAY - PRODUCT STATUS
  • FTD HDV RNA ASSAY - PRODUCT DESCRIPTION
  • RNA
  • United States
  • Company
  • Demand
  • GlobalData's company
  • Application
  • Indication
  • Genomics
  • Pathology
  • RNA
  • United States
  • GlobalData's company
  • GLOBAL ELECTROPHORESIS REAGENTS MARKET SIZE FOR DNA & RNA ANALYSIS, BY COUNTRY/REGION,...
  • REST OF EUROPE: ELECTROPHORESIS REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • Dye
  • RNA
  • Europe
  • World
  • Market Size
  • Small Molecules to Inhibit RNA Dependent RNA Polymerase for Common Cold
  • Small Molecules to Inhibit RNA Dependent RNA Polymerase for Dengue Virus...
  • Pharmaceutical
  • Research And Development
  • RNA
  • United States
  • Cocrystal Pharma, Inc.
  • Indication
  • Application
  • Diagnostics
  • Prostate Cancer
  • RNA
  • United States
  • Exosome Diagnostics, Inc.
  • SMALL MOLECULE TO TARGET RNA FOR MYOTONIC DYSTROPHY - DRUG PROFILE
  • SMALL MOLECULE TO TARGET CUG RNA FOR MYOTONIC DYSTROPHY 1 - DRUG PROFILE
  • Neurological Disorder
  • RNA
  • United States
  • Product Initiative
  • BioBlast Pharma Ltd.
  • Myotonic Dystrophy - Product Development Milestones
  • Drug Profiles

This platform targets two types of RNA, namely, coding RNA and non-coding RNA.

  • Genomics
  • Pharmaceutical
  • RNA
  • Therapy
  • United States
  • PIPELINE OF REPLICON RNA INFECTIOUS DISEASE VACCINES
  • 6. TECHNOLOGY ANALYSIS
  • Infectious Disease
  • RNA
  • Vaccine
  • United States
  • Moderna Therapeutics, Inc.
  • Electrochemiluminescent Based RNA Detection Platform - Product Description
  • Electrochemiluminescent Based RNA Detection Platform - Product Status
  • RNA
  • United States
  • Company
  • Product Initiative
  • GlobalData's company
  • BIOMARIN PHARMACEUTICAL INC. - DISCONTINUED PIPELINE PRODUCTS

It is RNA based therapeutic drug candidate.

  • Pharmaceutical
  • RNA
  • United States
  • Product Initiative
  • BioMarin Pharmaceutical Inc.

The company’s products include siLNA and sisiLNA unmodified RNA, RNA oligonucleotides modified with customer-specific amidites, and LNA-modified ##' -O-Me-RNA.

  • Genomics
  • RNA
  • M&A